Herbal compositions and methods for enhancing vital energy and athletic performance

• US 8,119,170 B2
• Filed: 11/30/2010
• Issued: 02/21/2012
• Est. Priority Date: 04/17/2008
• Status: Active Grant

• Current Assignee: Siboni Group Limited
• Original Assignee: Vivien Chou, Wen Hsien Chou
• Inventors: Chou, Wen Hsien, Chou, Vivien
• Primary Examiner(s): Flood, Michele
• Assistant Examiner(s): Davis, Deborah A.
• Application Number:
  US12/957,195
• Publication Number:
  US 20110091585A1
• Time in Patent Office: 448 Days
• Field of Search: None
• US Class Current: 424/752
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 36/16 Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
• CPC Class Codes: A61K 36/41 Crassulaceae (Stonecrop family)
• CPC Class Codes: A61P 21/00 Drugs for disorders of the muscular or neuromuscular system
• CPC Class Codes: A61P 25/00 Drugs for disorders of the nervous system
• CPC Class Codes: A61P 39/00 General protective or antinoxious agents
• CPC Class Codes: A61P 9/00 Drugs for disorders of the cardiovascular system
• CPC Class Codes: A61P 9/10 for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Compositions, kits and methods are provided for enhancing vital energy and athletic performance, improving or restoring blood circulation, promoting mental acuity, reducing fatigue, and improving aerobic performance. In one embodiment, the composition comprises the herbal extracts of Rhodiola crenulata (root) and Ginkgo biloba (leaf). The composition can be used as a pharmaceutical or nutraceutical to promote mental concentration, and to promote aerobic and anaerobic performance by enhancing strength, endurance, muscle tissue oxygenation, and optimal oxygen consumption.

Claims

1. A composition comprising about 90% w/w of a Rhodiola crenulata extract and about 10% w/w of a Ginkgo biloba extract based on the total weight of the composition, wherein the Rhodiola crenulata extract comprises at least about 0.10 w/w salidroside based on the total weight of the Rhodioa crenulata extract, and the Ginkgo biloba extract comprises at least about 0.10% w/w flavonoids based on the total weight of the Ginkgo biloba extract.

2. The composition of claim 1, further comprising one or more excipients.

3. The composition of claim 1, wherein the composition is a solid.

4. The composition of claim 1, wherein the composition is a liquid.

5. The composition of claim 1, wherein the herbal extract of Rhodiola crenulata comprises at least 1.0% w/w salidroside based on the total weight of the herbal extract.

6. The composition of claim 1, wherein the herbal extract of Rhodiola crenulata comprises 1.0%-5.0% w/w salidroside based on the total weight of the herbal extract.

7. The composition of claim 1, wherein the herbal extract of Ginkgo biloba comprises 0.10%-1.5% w/w flavonoids based on the total weight of the herbal extract.

8. A kit comprising at least one dose of an effective amount of the composition of claim 1.

9. The kit of claim 8, further comprising instruction of how to use the kit to improve or restore blood circulation, promote mental acuity, reduce fatigue, or promote aerobic or anaerobic performance.

10. The kit of claim 8, wherein more than one dose of an effective amount of the composition of claim 1 is included.

11. The kit of claim 8, further comprising a dispensing cup or a dispensing spoon.

12. A method for improving or restoring blood circulation in the body of a mammal comprising:

administering to the mammal in need thereof an effective amount of the composition of claim 1.

13. The method of claim 12, wherein said administration is oral.

14. The method of claim 12, wherein the composition is administered to a human at a dose of about 1-3200 mg/day, about 400-2000 mg/day, about 800-1600 mg/day, about 1200-1600 mg/day, or about 1000 mg/day.

15. The method of claim 12, wherein the composition is orally administered to a human at a dose of about 1-100 mg/kg, about 1-60 mg/kg, about 1-30 mg/kg, about 1-15 mg/kg, about 1-6 mg/kg or about 1-5 mg/kg once or twice a day.

16. A method for reducing fatigue or promoting aerobic performance in a mammal comprising:

administering to the mammal in need thereof an effective amount of the composition of claim 1.

17. The method of claim 16, wherein said administration is oral.

18. The method of claim 16 wherein the composition is administered to a human at a dose of about 1-3200 mg/day, about 400-2000 mg/day, about 800-1600 mg/day, about 1200-1600 mg/day, or about 1000 mg/day.

19. The method of claim 16, wherein the composition is orally administered to a human at a dose of about 1-100 mg/kg, about 1-60 mg/kg, about 1-30 mg/kg, about 1-15 mg/kg, about 1-6 mg/kg or about 1-5 mg/kg once or twice a day.